Advertisement

Update on Clostridium difficile from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, April 22–25, 2017

  • K. Davies
    Affiliations
    R&D Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

    Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK
    Search for articles by this author
  • J. Freeman
    Affiliations
    R&D Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

    Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK
    Search for articles by this author
  • S. Mayor
    Correspondence
    Corresponding author. Address: 42a Lee Park, Blackheath, London SE3 9HZ, UK. Tel.: +44 (0)20 83180151.
    Affiliations
    Freelance Medical Journalist and Editor, London, UK

    Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK
    Search for articles by this author
Published:December 01, 2017DOI:https://doi.org/10.1016/j.jhin.2017.11.016
      Clostridium difficile testing and epidemiology continued to be important subjects of discussion at ECCMID 2017. New data were presented showing the importance of Clostridium difficile infection (CDI) as a major contributor to the burden of hospital infections and the potential of new treatment strategies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Davies K.
        • Davis G.
        • Barbut F.
        • Eckert C.
        • Petrosillo N.
        • Pisapia R.
        • et al.
        Multivariate analysis of factors affecting Clostridium difficile infection rates; the more you look, the more you find, but should you believe what you see?.
        in: ECCMID. 2017 (Abstract OS0221)
        • Eyre D.W.
        • Davies K.
        • Davis G.
        • Fawley W.
        • Karas A.
        • Crook D.W.
        • et al.
        Clostridium difficile diversity across Europe from whole-genome sequencing.
        in: ECCMID. 2017 (Abstract OS0227)
        • Leonard A.
        • Robertson C.
        • Pan J.
        • Ford I.
        • McCowan C.
        • Walker A.
        • et al.
        Clinical outcomes following hospitalization with Clostridium difficile.
        in: ECCMID. 2017 (Abstract OS0224)
        • Enoch D.A.
        • Murray-Thomas T.
        • Dedman D.
        • Tretter R.
        • Adomakoh N.
        • Karas A.
        • et al.
        Retrospective cohort study of the risk of complications and all-cause mortality in adults with hospital-associated recurrent Clostridium difficile infection in England.
        in: ECCMID. 2017 (e-poster EPO181)
        • Rahav G.
        • Yacyshyn B.
        • Kao D.
        • Ellison M.C.
        • Pedley A.
        • Eves K.
        • et al.
        Efficacy of bezlotoxumab in patients with recurrent Clostridium difficile infection: pooled analysis of data from the MODIFY trials.
        in: ECCMID. 2017 (Abstract P2048)
        • Trucksis M.
        • Baird I.
        • Cornely O.A.
        • Golan Y.
        • Hecht G.
        • Pardi D.S.
        • et al.
        An analysis of results from the first placebo-controlled trial of single-dose SER-109, an investigational oral microbiome therapeutic to reduce the recurrence of Clostridium difficile infection (CDI).
        in: ECCMID. 2017 (Abstract OS0250)
        • Thorpe C.
        • Kane A.
        • Change J.
        • Vickers R.
        • Snydman D.R.
        Ridinilazole treatment for C. difficile infection preserves the intestinal microbiota of patients.
        in: ECCMID. 2017 (Abstract P2049)